Max Bayer – Page 5 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Moderna information chief to retire next month; Pharming looks to Flagship for first new CEO since 2008

4 months ago

As another Trump term gets underway, pharma advisors get comfortable with uncertainty

4 months ago

J&J reinforces Caplyta blockbuster projections, won't shelve neuro prospects

4 months ago

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’

4 months ago

J&J’s Spravato hit $1B in revenue in 2024

4 months ago

Renewed mifepristone fight will be early test of Trump’s abortion stance in his second term

4 months ago

Sage sues Biogen days after $469M buyout offer

4 months ago

Roche's cardiometabolic chief warns against weight loss 'obsession' with GLP-1s

4 months ago

Lykos upheaval continues with four new board exits amid hunt for cash

4 months ago

BIO CEO plans to join FDA modernization advisory board under Trump administration

4 months ago

Gottlieb says RFK Jr. as HHS secretary could bring ‘tragic’ outbreaks

4 months ago

Lawmakers ask Biden administration to tighten rules around China clinical trials

4 months ago

Lilly finances new $500M biotech fund managed by a16z

4 months ago

John Maraganore turns to ex-Alnylam colleague to lead his latest RNAi bet; Amylyx names commercial chief

4 months ago

IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint

4 months ago

MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment

4 months ago

Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labels at FDA's request

4 months ago

After a bump in adcomms in 2023, FDA advisory panels returned to 2022 levels

4 months ago

Pennsylvania Blue Cross insurer restricts coverage of medicines granted FDA accelerated approval

4 months ago

Flagship biotech Valo Health ends 2024 with mid-stage fail

5 months ago

WuXi AppTec will sell cell and gene therapy business to private equity firm

5 months ago

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

5 months ago

Sumitomo’s overactive bladder drug adds another indication

5 months ago

Daiichi Sankyo finds successor to late R&D exec; Versant, Novartis' kidney biotech poaches Sana CBO

5 months ago

First page Previous page 2 3 456 7 8 Next page Last page